Literature DB >> 27738915

History of Antibiotics Research.

Kathrin I Mohr1.   

Abstract

For thousands of years people were delivered helplessly to various kinds of infections, which often reached epidemic proportions and have cost the lives of millions of people. This is precisely the age since mankind has been thinking of infectious diseases and the question of their causes. However, due to a lack of knowledge, the search for strategies to fight, heal, and prevent the spread of communicable diseases was unsuccessful for a long time. It was not until the discovery of the healing effects of (antibiotic producing) molds, the first microscopic observations of microorganisms in the seventeenth century, the refutation of the abiogenesis theory, and the dissolution of the question "What is the nature of infectious diseases?" that the first milestones within the history of antibiotics research were set. Then new discoveries accelerated rapidly: Bacteria could be isolated and cultured and were identified as possible agents of diseases as well as producers of bioactive metabolites. At the same time the first synthetic antibiotics were developed and shortly thereafter, thousands of synthetic substances as well as millions of soil borne bacteria and fungi were screened for bioactivity within numerous microbial laboratories of pharmaceutical companies. New antibiotic classes with different targets were discovered as on assembly line production. With the beginning of the twentieth century, many of the diseases which reached epidemic proportions at the time-e.g., cholera, syphilis, plague, tuberculosis, or typhoid fever, just to name a few, could be combatted with new discovered antibiotics. It should be considered that hundred years ago the market launch of new antibiotics was significantly faster and less complicated than today (where it takes 10-12 years in average between the discovery of a new antibiotic until the launch). After the first euphoria it was quickly realized that bacteria are able to develop, acquire, and spread numerous resistance mechanisms. Whenever a new antibiotic reached the market it did not take long until scientists observed the first resistant germs. Since the marketing of the first antibiotic there is a neck-on-neck race between scientists who discover natural or develop semisynthetic and synthetic bioactive molecules and bacteria, which have developed resistance mechanisms. The emphasis of this chapter is to give an overview of the history of antibiotics research. The situation within the pre-antibiotic era as well as in the early antibiotic era will be described until the Golden Age of Antibiotics will conclude this time travel. The most important antibiotic classes, information about their discovery, activity spectrum, mode of action, resistance mechanisms, and current application will be presented.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27738915     DOI: 10.1007/82_2016_499

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  38 in total

1.  Safeguarding intestine cells against enteropathogenic Escherichia coli by intracellular protein reaction, a preventive antibacterial mechanism.

Authors:  Jiaming Qiu; Yunyu Nie; Yuan Zhao; Yu Zhang; Linting Li; Rui Wang; Miaomiao Wang; Sheng Chen; Jianhao Wang; Yong-Qiang Li; Jiang Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

2.  Computational and Biological Evaluation of β-Adrenoreceptor Blockers as Promising Bacterial Anti-Virulence Agents.

Authors:  Ahmad J Almalki; Tarek S Ibrahim; Sameh S Elhady; Wael A H Hegazy; Khaled M Darwish
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-18

3.  Salted duck eggs: the source for pathogens and antibiotic resistant bacteria.

Authors:  Lin Yang; Junli Zhang; Qing Wan; Zhijing Xue; Wanda Tang; Ruiling Zhang; Zhong Zhang
Journal:  J Food Sci Technol       Date:  2021-01-12       Impact factor: 2.701

Review 4.  Ten decadal advances in fungal biology leading towards human well-being.

Authors:  Ausana Mapook; Kevin D Hyde; Khadija Hassan; Blondelle Matio Kemkuignou; Adéla Čmoková; Frank Surup; Eric Kuhnert; Pathompong Paomephan; Tian Cheng; Sybren de Hoog; Yinggai Song; Ruvishika S Jayawardena; Abdullah M S Al-Hatmi; Tokameh Mahmoudi; Nadia Ponts; Lena Studt-Reinhold; Florence Richard-Forget; K W Thilini Chethana; Dulanjalee L Harishchandra; Peter E Mortimer; Huili Li; Saisamorm Lumyong; Worawoot Aiduang; Jaturong Kumla; Nakarin Suwannarach; Chitrabhanu S Bhunjun; Feng-Ming Yu; Qi Zhao; Doug Schaefer; Marc Stadler
Journal:  Fungal Divers       Date:  2022-09-15       Impact factor: 24.902

5.  Discovery of a Novel Antimicrobial Peptide, Temporin-PKE, from the Skin Secretion of Pelophylax kl. esculentus, and Evaluation of Its Structure-Activity Relationships.

Authors:  Yaxian Lin; Yangyang Jiang; Ziwei Zhao; Yueyang Lu; Xinping Xi; Chengbang Ma; Xiaoling Chen; Mei Zhou; Tianbao Chen; Chris Shaw; Lei Wang
Journal:  Biomolecules       Date:  2022-05-29

6.  Microbial Antagonism in Food-Enrichment Culture: Inhibition of Shiga Toxin-Producing Escherichia coli and Shigella Species.

Authors:  Tanis C McMahon; Cesar Bin Kingombe; Amit Mathews; Karine Seyer; Alex Wong; Burton W Blais; Catherine D Carrillo
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064

7.  Screening of diverse marine invertebrate extracts identified Lissoclinotoxin F, Discodermin B, and other anti-Mycobacterium tuberculosis active compounds.

Authors:  Henok A Sahile; David E Williams; Nicole J de Voogd; Mary Ko; Raymond J Andersen; Yossef Av-Gay
Journal:  J Antibiot (Tokyo)       Date:  2022-01-28       Impact factor: 3.424

8.  Clinical study of herbal mixture "Diding Oral Medicine" as an alternative to preventative antibiotics in perioperative hemorrhoids: A CARE-compliant article.

Authors:  Hengqing Gao; Xiaohong Cheng; Runping Liu; Xiaoqiang Wang; Wei Wang; Furao Gong; Renping Pan; Jing Hu
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

9.  Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the pqs Quorum-Sensing System of Pseudomonas aeruginosa.

Authors:  Francesca D'Angelo; Valerio Baldelli; Nigel Halliday; Paolo Pantalone; Fabio Polticelli; Ersilia Fiscarelli; Paul Williams; Paolo Visca; Livia Leoni; Giordano Rampioni
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 10.  Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.

Authors:  Natalie K Boyd; Chengwen Teng; Christopher R Frei
Journal:  Front Cell Infect Microbiol       Date:  2021-05-17       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.